Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03589222
Title SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Germans Trials i Pujol RECRUITING Badalona Spain Details
Hospital Clinic de Barcelona RECRUITING Barcelona Spain Details
Hospital ICO de Girona RECRUITING Girona Spain Details
Hospital ICO de L'hospitalet RECRUITING L'Hospitalet De Llobregat Spain Details
Hospital 12 de Octubre RECRUITING Madrid Spain Details
Hospital Clinico de Madrid RECRUITING Madrid Spain Details
Hospital Morales Meseguer RECRUITING Murcia Spain Details
Hospital Central de Asturias RECRUITING Oviedo Spain Details
Clinica Universitaria de Navarra RECRUITING Pamplona Spain Details
Hospital Clinico Universitario de Salamanca RECRUITING Salamanca Spain Details
Hospital Universitario de Donostia RECRUITING San Sebastián Spain Details
Hospital Universitario de Santiago RECRUITING Santiago De Compostela Spain Details
Hospital Virgen del Rocio RECRUITING Sevilla Spain Details
Hospital Universitario de Canarias RECRUITING Tenerife Spain Details
Hospital Dr Peset RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field